Categories: News

Icario’s Annual Healthcare Innovation Summit Trailblaze 2022 Taking Place Aug. 10-11 in Minneapolis

Speakers Include Blue Zones Founder and Bestselling Author Dan Buettner and Healthcare Leaders From Aetna/CVS Health, Anthem, Medicaid Health Plans of America, UnitedHealthcare, Walmart Health

MINNEAPOLIS, June 22, 2022 (GLOBE NEWSWIRE) — Icario, the healthcare industry’s largest health action company, today announced registration is now open for Trailblaze 2022, the company’s annual healthcare innovation summit. This year’s event will take place on Aug. 10 and 11 at the Nicollet Island Pavilion in Minneapolis.

What: Trailblaze 2022

Who: New York Times bestselling author and Blue Zones founder Dan Buettner will deliver an inspirational keynote. Other speakers include leaders from Anthem, Medicaid Health Plans of America, UnitedHealthcare, Social Innovation Ventures, CVS Health | Aetna, Walmart Health, Vail Place, and Icario.

When: Aug. 10 and 11

Where: Nicollet Island Pavilion, 40 Power Street, Minneapolis, MN.

Event Info: Trailblaze 2022 is designed to energize, inspire and provide insights into the fast-moving healthcare industry. Attendees will collaborate and learn alongside some of the brightest minds in healthcare on the hottest topics and trends and leave with actionable insights to share with their teams. Registration is available here. A full agenda can be found at https://trailblazesummit.com.

About Icario
Icario is the leading health action company focused on connecting people to health. Icario uses pioneering behavioral research, data science, and our adaptive multi-channel platform to deliver personalization at scale for the most trusted healthcare organizations in all 50 states, including eight of the ten largest health plans. Learn more at www.icariohealth.com.

BOCA Communications for Icario
icario@bocacommunications.com

Staff

Recent Posts

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

3 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

3 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

3 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

3 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

3 hours ago

PulseAI Secures Seed Funding to Advance AI-Driven ECG Diagnostics

BELFAST, Northern Ireland  , Jan. 12, 2026 /PRNewswire/ -- PulseAI, a rapidly emerging leader in…

3 hours ago